Form S-8 Taysha Gene Therapies,

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. MRK
7. LVS
8. SAP
9. CSX
10. LRCX

Go back to Form S-8 Taysha Gene Therapies,

Taysha Gene Therapies (TSHA) PT Lowered to $31 at Jefferies

April 1, 2022 8:46 AM EDT

Jefferies analyst Eun Yang lowered the price target on Taysha Gene Therapies (NASDAQ: TSHA) to $31.00 (from $41.00) while maintaining a Buy rating.

The analyst commented, "Prioritization of several key pipeline programs is positive (vs prior >20 gene therapy programs in development),... More

Taysha Gene Therapies (TSHA) PT Lowered to $37 at Oppenheimer

April 1, 2022 8:18 AM EDT

Oppenheimer analyst Kevin DeGeeter lowered the price target on Taysha Gene Therapies (NASDAQ: TSHA) to $37.00 (from $45.00) while maintaining a Outperform rating.

The analyst commented, "TSHA disclosed restructuring to focus on giant axonal neuropathy (GAN) and Rett syndrome, confirming suggestive comments at our 3/15 conference (note). Restructuring includes:... More